Market Overview

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of ARMO BioSciences, Inc. (ARMO) on Behalf of Stockholders and Encourages Investors to Contact the Firm


Bragar Eagel & Squire, P.C. is investigating potential claims on behalf
of ARMO BioSciences, Inc. (NASDAQ:ARMO) stockholders concerning the
proposed acquisition of the company by Eli Lilly and Company (NYSE:LLY).

Our investigation concerns whether ARMO's board of directors failed to
adequately shop the Company and obtain the best possible value for its
stockholders before entering into a definitive merger agreement with Eli
Lilly. Under the terms of the agreement, ARMO stockholders will receive
$50.00 per share in cash for each ARMO share that they own.

If you own ARMO shares, have information, would like to learn more about
these claims, or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Brandon Walker or Melissa Fortunato by email at,
or telephone at (212) 355-4648, or by filling
out this contact form
. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating
in commercial and securities litigation. For additional information
concerning our investigation of ARMO BioSciences, Inc., please go to
For additional information about Bragar Eagel & Squire, P.C., please go

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial